Table 1.
Correlation of osteopontin expression with clinical-pathological characteristics.
| Characteristics | Total (%) | Positive (%) | Negative (%) | P-value |
|---|---|---|---|---|
| Age | 0.152 | |||
| <60y | 35 (43.8) | 6 (7.5) | 29 (36.3) | |
| >60y | 45 (56.2) | 14 (17.5) | 31 (31.7) | |
| ECOG PS | 0.199 | |||
| 0,1 | 57 (71.3) | 12(15) | 45 (56.3) | |
| >/=2 | 23 (28.7) | 8(10) | 15 (18.7) | |
| Ann Arbor stage | 0.330 | |||
| I,II | 25 (31.3) | 8(10) | 17 (21.3) | |
| III, IV | 55 (68.7) | 12(15) | 43 (53.7) | |
| LDH | 0.691 | |||
| Normal | 31 (38.7) | 7 (8.7) | 24(30) | |
| Increased | 49 (61.3) | 13 (16.3) | 36(45) | |
| Extranodal disease | 0.424 | |||
| Negative | 30 (37.5) | 6 (7.5) | 24(30) | |
| Positive | 50 (62.5) | 14 (17.5) | 36(45) | |
| Cell origin | 0.040 | |||
| Germinal center | 42 (59.2) | 8 (11.3) | 34 (47.9) | |
| Non-germinal center | 29 (40.8) | 12 (16.9) | 17 (23.9) |